Elias Kouchakji, SVP, Clinical Development, Drug Safety at FIBROGEN INC (FGEN), sold 2,873 shares at $45.00 ($129K) on 2019-06-28, disclosed to the SEC on 2019-07-02.
Open-market sale of $129k FGEN by SVP, Clinical Development, Drug Safety. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.